Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
Weijia Li(Jacobi Medical Center), Damianos G. Kokkinidis(Memorial Hospital of South Bend), Stefanos Giannopoulos(Denver VA Medical Center), Dimitrios Kalaitzoglou(National and Kapodistrian University of Athens), Yu-Chiang Wang(Jacobi Medical Center), Apostolos Manolopoulos(National Institute on Aging), Leonidas Palaiodimos(Albert Einstein College of Medicine), Paraschos Archontakis‐Barakakis(Albert Einstein College of Medicine), Robert Faillace(Jacobi Medical Center), Lazaros Tzelves(National and Kapodistrian University of Athens)
Cited by 7
Related Papers
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity
|JAMA Cardiology|2019|418
Best Practice in Interventional Management of Urolithiasis: An Update from the European Association of Urology Guidelines Panel for Urolithiasis 2022
|European Urology Focus|2022|252
European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis
|European Urology|2025|141
Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer’s Disease: a Systematic Review and Meta-Analysis
|Journal of General Internal Medicine|2021|125